Latest News

doctor talking about biosimilars | Image credit: Suteren Studio -
Real-World Study: No Increase in Health Resource Costs After Infliximab Biosimilar Introduction

July 20th 2024

Although biosimilars reduce drug purchasing costs for hospitals, it’s unclear whether those savings might be offset by increased health resource utilization following a non-medical switching initiative.

doctor patient biosimilar | Image credit: Prostock-studio -
Samsung Bioepis’ Ustekinumab Biosimilar Demonstrates PK Equivalence in Healthy Adults

July 6th 2024

fda approved | Image credit: Argus -
FDA Approves Samsung Bioepis’ Pyzchiva, a Biosimilar to Stelara

July 1st 2024

syringes for subcutaneous injection | Image credit: SOPONE -
Phase 3 Trials Find Subcutaneous Infliximab CT-P13 Superior to Placebo in IBD

June 29th 2024

UK healthcare and biosimilars | Image credit: millaf -
Biosimilar Adoption in the UK: Patient and Consultant Views on Safety and Switching

June 26th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.